Last reviewed · How we verify

NCT04385693

Intentional Pulpotomy to Preserve Hopeless Molars

Completed NA Last updated 6 June 2023
What this trial tests

NA trial testing Pulpotomy in Pulpitis in 17 participants. Completed in 12 April 2023.

Timeline
12 June 2020
Primary endpoint
12 April 2023
12 April 2023

Quick facts

Lead sponsorUniversity of Florida
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment17
Start date12 June 2020
Primary completion12 April 2023
Estimated completion12 April 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Florida

Who can join

Adults 5 to 10, any sex, with Pulpitis or Dental Pulp Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

When proximal carious lesions of primary molars are located in close proximity to the cementum enamel junction (CEJ), marginal seal is challenging and extraction is recommended. Pulpotomy is indicated for vital primary teeth to preserve them in function. The goal of this study is to monitor the long-term effect of intentional bioactive cement pulpotomies and crown coverage performed on vital and asymptomatic carious primary molars with gingival margins close to or at the CEJ

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Pulpotomy

Trials testing the same drug.

Other recruiting trials for Pulpitis

Currently open trials in the same condition.

Other University of Florida trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04385693.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing